Ads
    Related paper
  1. Dynamics of endothelial dysfunction, nephropathic and dyslipidemic disorders in patients with insufficient glycemic compensation of type 2 diabetes mellitus during 1 year of application of angiotensin II receptor antagonists for hypertension correction
  2. DAMAGE OF RENAL FUNCTION AND DYNAMICS OF DYSLIPIDEMIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH INSUFFICIENT GLYCEMIC COMPENSATION UNDER CONDITION OF CORRECTION OF HYPERTENSION WITH ANGIOTENSIN II RECEPTOR ANTAGONISTS
  3. Addition of Metformin to Liraglutide, A GLP-1 Receptor Agonist, Improves Glycemic Control in Patients with Type 2 Diabetes Mellitus
  4. GLUCOSE METABOLISM CHARACTERISTICS AND THE I/D GENE POLYMORPHISM OF THE ANGIOTENSIN-CONVERTING ENZYME IN THE PATIENTS WITH ARTERIAL HYPERTENSION ACCOMPANYING WITH A TYPE II DIABETES MELLITUS
  5. Endothelial function in patients with diabetes mellitus type 2 with arterial hypertension in good compensation of hyperglycemia
  6. Glycemic Control, Medication Use and Obesity among Patients with Type 2 Diabetes Mellitus Presenting to an Endocrinology Clinic during the War in Yemen. A Three-Year Retrospective Study
  7. NEPHROPATHIC CHARACTERISTICS IN PATIENTS WITH DIABETES MELLITUS TYPE 2 AND ESSENTIAL HYPERTENSIVE DISEASE
  8. Relationship of endothelial dysfunction with degree of renal function damage and lipidemic profile in patients with type 2 diabetes mellitus and hypertension
  9. Paternal Influence on Glycemic Control at Baseline and One Year Post Diagnosis in Children and Adolescents with Type 1 Diabetes Mellitus
  10. An experience of application of telmisartan (micardis) in therapy of patients with diabetes mellitus type 2, diabetic nephropathya and arterial hypertension